Knockout experiments targeting GAS5 or SMARCA4 and overexpression of miR-423-3p demonstrated reduced tumorigenesis, highlighting the oncogenic role of the GAS5–miR-423-3p–SMARCA4 axis in HCC progression. The gene discussed is SMARCA4; the disease is hepatocellular carcinoma.